Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
04/16/2003 | CN1410835A Organic photoreceptor for electronic photographing |
04/16/2003 | CN1410834A Organic light receptor with charge transfer compound for electronic photographing |
04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
04/15/2003 | US6548532 Topically applying onto the afflicted skin and/or scalp cosmetically/ therapeutically effective amount of indolecarboxylic acid compound, or ester or salt thereof |
04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
04/15/2003 | CA2172854C Antimicrobial indole derivatives |
04/15/2003 | CA2099588C Prevention of synovial adhesions |
04/10/2003 | WO2003029226A1 Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides |
04/10/2003 | WO2003029214A1 Pseudopolymorphic forms of carvedilol |
04/10/2003 | WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
04/10/2003 | WO2003029212A1 Indole derivatives as cox ii inhibitors |
04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
04/10/2003 | WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
04/10/2003 | WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
04/10/2003 | WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents |
04/10/2003 | WO2003007069A3 Novel nonlinear optical polymers |
04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
04/10/2003 | WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders |
04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
04/10/2003 | US20030069431 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
04/10/2003 | US20030069416 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives |
04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
04/10/2003 | US20030069299 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
04/10/2003 | US20030069297 4-aryl substituted indolinones |
04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
04/10/2003 | US20030069245 Aids therapy |
04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
04/10/2003 | US20030069225 Synthesis of taxol enhancers |
04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
04/10/2003 | CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
04/10/2003 | CA2461670A1 Indole derivatives as cox ii inhibitors |
04/10/2003 | CA2460486A1 Pseudopolymorphic forms of carvedilol |
04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
04/09/2003 | EP1299774A1 Perfluoroalkylsulfonic acid compounds for photoresists |
04/09/2003 | EP1299722A1 Methods for encoding combinatorial libraries |
04/09/2003 | EP1299401A1 Chiral ligands for asymmetric catalysis |
04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
04/09/2003 | EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
04/09/2003 | EP1299101A1 Carvedilol |
04/09/2003 | EP1198453B1 N-(indolcarbonyl-)piperazin derivatives |
04/09/2003 | EP0993458B1 3-benzylpiperidine |
04/09/2003 | EP0850224B1 Radiation-activated cytotoxin therapy |
04/09/2003 | EP0792257B1 Material for dichroic light polarizers |
04/09/2003 | CN1409729A Substituted group-4 metal complexes, catalysts and olefin polymerization process |
04/09/2003 | CN1105103C Amino-iminoisoindolenine benzene sulfonate, and process for preparation of nitrate and benzene sulfonate salts of amino-aminoiso indolenine derivatives |
04/08/2003 | US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
04/08/2003 | US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors |
04/08/2003 | US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. |
04/08/2003 | US6545051 Antibacterial hydroxamic acid derivatives |
04/08/2003 | US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group |
04/08/2003 | US6545035 Substituted indolinones with kinase inhibitory activity |
04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
04/08/2003 | US6544970 Administering in a first phase of a progestational agent (levonorgestrel or ethinylestradiol) and in a second phase an antiprogestin that is an indolinone derivative, especially a 3-spiroalkylene derivative |
04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
04/08/2003 | CA2123548C Piperazine derivatives |
04/08/2003 | CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles |
04/03/2003 | WO2003027314A2 Protected linker compounds |
04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
04/03/2003 | WO2003027089A1 Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
04/03/2003 | WO2003027071A1 Method for preparing n-($g(v)-bromoalkyl)phthalimides |
04/03/2003 | WO2003027070A1 Method for preparing n-($g(v)-bromoalkyl)phthalimides |
04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
04/03/2003 | WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these |
04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
04/03/2003 | US20030065219 Cyclization of an alcohol containing urea compound |
04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
04/03/2003 | US20030065031 Glucagon antagonists/inverse agonists |
04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
04/03/2003 | US20030064995 Antidepressants, anxiolytic agents |
04/03/2003 | US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
04/03/2003 | US20030064977 Viricides |
04/03/2003 | US20030064246 Blue light emitting compound and organic electroluminescent device employing the same as color developing substance |
04/03/2003 | US20030063365 Electrochromic solution containing hydrazone compound and device manufactured with same |
04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
04/02/2003 | EP1298496A2 Electrophotographic organophotoreceptors |
04/02/2003 | EP1297833A1 Indole carboxylic acids as thyroid receptor ligands |
04/02/2003 | EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding |
04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
04/02/2003 | EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
04/02/2003 | EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
04/02/2003 | EP1296942A1 Glucagon antagonists/inverse agonists |
04/02/2003 | EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |